Rayner will offer the most complete family of trifocal IOLs in the industry, allowing surgeons to treat an even wider range of presbyopic patients: Sulcoflex Trifocal, RayOne Trifocal and new RayOne Trifocal Toric. High patient satisfaction and spectacle independence reported from a multicentre pilot study. RayOne Trifocal Toric’s cylinder range starts from +0.75 D, allowing

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, announces today that it has successfully implanted the first lenses in the RayOne Galaxy IOL U.S. Food and Drug Administration (FDA) approved Investigational Device Exemption (IDE) Study.  The study is prospective, multicenter, randomised, masked and active controlled. If successful, the results of

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, is delighted to announce that it has now closed recruitment in the Investigational Device Exemption (IDE) study for the EMV Toric Intraocular lens in the USA. The study reflects Rayner’s continued focus on optimising visual outcomes for surgeons and their patients and

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, proudly announces delivery of its 5 millionth RayOne lens (and 11 millionth lens made from RayAcryl Rayner’s proprietary hydrophilic acrylic material), marking an important milestone in units sold globally. RayOne is Rayner’s fully-preloaded intraocular lens (IOL) injection system, providing smooth, consistent rolling

Mississauga, ON, 23 January 2024 Rayner, a global leader in products for cataract surgery, proudly announces the approval of RayOne EMV (RAO200E) by Health Canada1. Developed in collaboration with Professor Graham Barrett, RayOne EMV is the only patented aspheric IOL that induces controlled positive spherical aberration to slightly extend the depth of focus. “I’ve been awaiting

Rayner, a renowned global leader in innovative ophthalmic solutions and the pioneering manufacturer of the world’s first intraocular lens (IOL) in 1949, proudly announces a significant achievement in their ongoing dedication to improving vision. Last month, the company celebrates the successful implantation of their 4 millionth RayOne IOL, underscoring their commitment to advancing eye care

16 September 2022. Worthing, United Kingdom – Rayner, the pioneering manufacturer and supplier of ophthalmic solutions for cataract and refractive surgery, today announced that the world’s first implantations of RayOne EMV Toric had been performed by two highly respected surgeons from the UK. RayOne EMV Toric is the awaited toric variant of Rayner’s popular RayOne

JANUARY 05, 2022 – Worthing, United Kingdom. Rayner, the only UK manufacturer of intraocular lenses (IOLs), today announced the launch of RayOne Hydrophobic BLF. Made of its proprietary ultra glistening-free hydrophobic material, RayOne Hydrophobic BLF is Rayner’s first blue light filtering IOL. RayOne Hydrophobic BLF expands Rayner’s RayOne lens portfolio from seven to eight variants, now with

New York, USA, May 17, 2021 – RayOne Spheric, a fully-preloaded monofocal IOL, has received FDA approval. This achievement marks Rayner’s third FDA approval in under three years within its expanding RayOne preloaded IOL portfolio. RayOne Spheric joins RayOne Aspheric (FDA approved December 2018) and RayOne EMV, a new non-diffractive IOL solution which achieved FDA

Takeaways: Rayner’s fully preloaded RayOne Aspheric IOL has received NMPA approval for sale in China. RayOne Aspheric will be showcased at the 21st CSCRS from 3-5 June 2021 in Dalian. RayOne Aspheric offers a premium alternative to Rayner’s C-flex/Superflex Aspheric monofocal IOLs. Rayner’s award-winning RayOne IOL platform has been used in over 1.6 million procedures since 2016. Rayner will next

New York, USA, March 26, 2021 – RayOne EMV, a new fully preloaded non-diffractive IOL, has received FDA approval. RayOne EMV was developed in collaboration with world renowned surgeon Professor Graham Barrett, president of the Australasian Society of Cataract & Refractive Surgeons. “I collaborated with Rayner on bringing to market RayOne EMV, an exciting new product

Worthing (UK) – Rayner, the manufacturer of the world’s first Intraocular Lens (IOL), has been recognised for its excellence in innovation by winning the esteemed and internationally recognised Queen’s Award for Enterprise (QAE) for its RayOne fully preloaded IOL injection system, designed to create the smallest fully preloaded IOL incision during cataract surgery. Now in

Worthing (UK) – Rayner, the manufacturer of the world’s first Intraocular Lens (IOL), has been recognised for its excellence in innovation by winning the esteemed and internationally recognised Queen’s Award for Enterprise (QAE) for its RayOne fully preloaded IOL injection system, designed to create the smallest fully preloaded IOL incision during cataract surgery. Now in

Rayner will offer the most complete family of trifocal IOLs in the industry, allowing surgeons to treat an even wider range of presbyopic patients: Sulcoflex Trifocal, RayOne Trifocal and new RayOne Trifocal Toric. High patient satisfaction and spectacle independence reported from a multicentre pilot study. RayOne Trifocal Toric’s cylinder range starts from +0.75 D, allowing

Rayner, manufacturer of the world’s first IOL designed by Sir Harold Ridley, announced today that the US Food and Drugs Administration (FDA) have approved the RayOne Aspheric fully preloaded IOL injection system for use in the United States of America. Product approval details The FDA granted regulatory approval and sale of the RayOne Aspheric Monofocal

A Satellite Symposium sponsored by Rayner at the 2018 ESCRS on Sunday 23rd September at 1pm Professor Oliver Findl, Dr Tiago Ferreira, Professor Michael Amon, Dr Alessandro Mularoni, Dr Fernando Llovet-Osuna and Dr Martin Kacerovsky complete the panel of speakers for the Rayner-sponsored satellite symposium ‘Rayner: Leading the way to offer more patients a trifocal

For immediate release. Date: 05 March, 2018. RayOne Fully Preloaded IOL injection system now available in Argentina Rayner, together with Iskowitz – Rayner’s exclusive distributor in Argentina — announced today that the RayOne fully preloaded IOL injection system has received approval from the Argentine regulator, ‘Administración Nacional de Medicamentos, Alimentos y Tecnología Médica’ (ANMAT), and is now

For immediate release. Date: 17 October, 2017. Surgeons in India to access RayOne fully preloaded IOL injection system. British IOL manufacturer, Rayner, announced today that their new RayOne fully preloaded IOL injection system has received Central Drugs Standard Organisation (CDSCO) approval and is being launched in India. Product approval details The CDSCO granted regulatory approval and sale

For immediate release. 14 September, 2017. Rayner are proud to announce the launch of the newest member of the RayOne family of preloaded IOLs: the RayOne Trifocal, to be unveiled at the upcoming 2017 ESCRS conference in Lisbon. Product availability will be from 9 October 2017 to all CE registered markets. The most advanced lens design Rayner

For immediate release. Date: 11 July, 2017. RayOne Fully Preloaded IOL Injection System. Now available in Brazil. More surgeons to access the smallest Fully Preloaded IOL Incision Rayner announced today the latest update in the RayOne story: registration of the RayOne Aspheric and Spheric monofocal fully preloaded IOL injection systems has been listed in the Federal Register

An experimental study was recently conducted to compare current fully preloaded intraocular lens (IOL) injection systems on the market. 

The study explored wound architecture after IOL implantation and the overall ease and speed...

The new-look Rayner booth -- designed specifically with RayOne^® demos in mind -- was inundated with traffic. Surgeons clamored to experience the highly anticipated, fully preloaded IOL injection system at the recent XXXIV Congres...

For immediate release. Date: 1st September, 2016 The Smallest Fully Preloaded IOL Incision. Rayner set to launch RayOne at the Upcoming ESCRS Following the recent receipt of CE mark approval, Rayner are proud to announce the launch of RayOne: their fully preloaded IOL injection system to be unveiled at the upcoming ESCRS in Copenhagen. This flagship launch is

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, today announces the upcoming launch of the world’s first spiral IOL designed with artificial intelligence: RayOne Galaxy and Galaxy Toric. Launching at this year’s ESCRS Congress in Barcelona, the RayOne Galaxy IOL comes to market precisely 75 years after Rayner pioneered the

Rayner, a global manufacturer of products for cataract surgery headquartered in Worthing, UK, is proud to introduce their latest packaging, updated to reduce their carbon footprint, as a contribution to their environmental goals, and to improve ease of use for customers. The new packaging will include: Replacing traditional paper IFU documents with a QR code

Worthing, United Kingdom – August 11, 2023: Rayner, a global ophthalmic leader in Devices, Drugs and Digital, is pleased to announce the successful completion of the first implantations in two pivotal market access studies in China and the USA. In April, Rayner received approval from the People’s Republic of China’s Ministry of Science and Technology

The first seven episodes of ‘Peer2Peer: The Podcast’ are now available, featuring Dr Lisa Nijm (USA), Dr Paul Singh (USA), Dr Stefanie Schmickler (Germany), Dr Josefina Botta (Argentina), Dr Karl Stonecipher (USA), Professor Graham Barrett (Australia), Mr Paul Rosen (UK), Mr Allon Barsam (UK), Mr Andrew Turnbull (UK), Dr Eric Donnenfeld (USA) and Dr Jerry

Rayner sponsors ESCRS satellite symposium When: Sunday 18th September, 13.00-14.00 Where: Room Blue 2 Professor Oliver Findl (Austria), Professor Gerd Auffarth (Germany), Mr Allon Barsam (United Kingdom), Dr Başak Bostanci (Turkey) and Dr Tiago Ferreira (Portugal) complete the panel of surgeons for the Rayner-sponsored satellite symposium: Challenges in cataract surgery and advanced technology IOL solutions.

Worthing-based Rayner today announced the launch of its new patient education toolkit: YourVision.YourWorld. Comprising an extensive suite of digital and print materials, the toolkit has been created to help patients navigate cataract surgery and the increasing number of intraocular lens (IOL) options available to them. Patients with visual and cognitive impairments will benefit from the

Worthing, United Kingdom. Leading ophthalmology company Rayner has today announced its direct entry into the French cataract and refractive market. Based out of Lille in the Hauts-de-France region, Rayner has a growing team of experienced Ophthalmic Specialist Area Managers, focused on delivering the highest levels of service and support. Through this team, French ophthalmologists now

JANUARY 19, 2022 – Worthing, United Kingdom. Rayner, a leading ophthalmology company and the only British manufacturer of intraocular lenses (IOLs), announced today that it now has a direct sales presence in Australia as it continues its global commercial expansion. Previously distributed through Designs For Vision, Rayner will now sell its products directly to surgeons and hospitals

DECEMBER 22, 2021 – Worthing, United Kingdom. Rayner, a leading UK-based ophthalmic company focused on optimising visual outcomes for surgeons and their patients, is delighted to announce the appointment of Drs Eric Donnenfeld, Kerry Solomon, Vance Thompson, and Mr Jim Mazzo as strategic advisors to the business, with a specific focus on supporting the expansion

Join the conversation Following the launch of our new RayOne EMV intraocular lens, Plus1 EMV shines a light on the changing landscape of presbyopia correction in cataract and refractive surgery. With a global calendar of webinars, interviews, articles, social media and in-person events, join the conversation with leading surgeons from around the world. Join us on

NOVEMBER 24, 2021 – Worthing, United Kingdom. Rayner, a leading ophthalmology company focused on optimising visual outcomes for patients and surgeons, today announced the appointment of Dr Rob Nadler to the role of VP Corporate Development. Dr Nadler will play a critical role on the executive team, overseeing the company’s M&A strategy and brings invaluable clinical,

AUGUST 04, 2021 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract and refractive surgery, announced today that it has achieved the milestone figure of 1,000 intraocular lenses recorded on RayPRO, its digital patient reported outcomes platform. Launched at ASCRS in 2019 for ophthalmic surgeons who perform cataract procedures, RayPRO is

Worthing, UK, 3 May 2021 – With the global rollout of the RayOne EMV™ intraocular lens to markets around the world, Rayner announces today an exciting new campaign intended to extoll the benefits of monovision (including “Mini”, “Micro”, or “Blended”). The Plus1 EMV: A global discussion on Enhanced Monovision™ campaign will shine a light on

Worthing, UK – Rayner, the only British manufacturer of intraocular lenses (IOLs), has been successfully awarded Authorised Economic Operator (AEO) status by HM Revenue & Customs. AEO status is an internationally recognised quality mark indicating that Rayner’s role in the international supply chain is secure and that its customs controls and procedures are efficient and

Worthing, UK – Following the recent approval of incorporation, Rayner is proud to announce its direct entry into the Canadian ophthalmology market. Led by Wade Allen, Director: Americas, Rayner Surgical Corp will now be offering the Rayner portfolio of IOLs and injectors directly to Canadian surgeons. Rayner Surgical Corp has recently had the RayOne Aspheric

Rayner set to launch RayOne EMV in early October Worthing, UK, September 21st, 2020 – Rayner has announced the upcoming launch of RayOne EMV: a new fully preloaded non-diffractive IOL solution designed specifically to enhance patient outcomes achieved with monovision. Enhanced range of vision Developed in collaboration with Professor Graham Barrett, president of the Australasian

For immediate release Worthing, UK, July 22, 2020 – Rayner, the only UK manufacturer of Intraocular Lenses (IOLs) for treating cataracts and a winner of the 2020 Queen’s Awards for Enterprise (Innovation), announced today that changes to their manufacturing and packaging procedures will reduce CO2 greenhouse gas emissions by more than 800 tonnes over the

Rayner hosted its first surgeon clinical education webinar on 27 May 2020, with attendees from over 47 countries. Over the course of one hour, the three presenters spoke about returning to clinic (including associated safety precautions), their experience with premium trifocal IOLs, and the utilisation of contactless telehealth. The webinar was concluded with a busy

Wednesday 27th May (1 hour) Join an international panel of expert speakers as they share their experiences with premium trifocal intraocular lenses (IOLs), and discuss the importance of Patient Reported Outcomes (PROs). The speakers will also talk about returning to clinic after COVID-19. The webinar will last 1 hour (includes 15-minute Question & Answer session).

In order to serve hospitals, surgeons and patients around the world in need of cataract surgery and ophthalmic treatment, Rayner has today opened its commercial office. This means that our customer service, technical support and logistics teams are available to serve our customers as normal. Our factory never stopped producing our award-winning intraocular lenses meaning

Worthing (UK) – Rayner, the only UK manufacturer of Intraocular Lenses (IOLs) for treating cataracts and last month revealed as a winner of the 2020 Queen’s Awards for Enterprise (Innovation) for its RayOne IOL injector system, announced today that it substantially increased IOL production levels between January and April, despite NHS elective surgery being postponed

Rayner partners and acquires stake in Reper to drive R&D and build presence in Russia. Following a four-year R&D collaboration on a novel hydrophobic IOL material, Rayner has acquired a substantial stake in Reper, a leading material science and medical device company based in Russia. The new proprietary non-glistening material is the basis for RayOne

Nat joined Rayner in 2004 with a degree in Mechanical Engineering, initially gaining experience across a diverse range of areas including new product development and design control, but also risk management, equipment design & validation, clinical writing and post market surveillance. More recently he achieved a Certificate in Company Direction (Dist) from the IoD and

For Immediate Release Date: 7th August 2018 Rayner are proud to announce the launch of the new, CE marked Sulcoflex Trifocal Pseudophakic Supplementary IOL at the 2018 ESCRS in Vienna. Rayner’s most technologically advanced IOL The Sulcoflex Trifocal combines Rayner’s pseudophakic supplementary Sulcoflex platform — designed to be implanted in the ciliary sulcus and with over ten

RayOne Hydrophobic, Rayner’s first fully preloaded IOL system with a hydrophobic acrylic lens, is now available to CE Mark-accepting countries. Daily compromises faced by cataract surgeons are eliminated with a new proprietary material, unique Cornerstone lens shape and intuitive fully preloaded injector. Worthing (UK), May 22nd, 2018 – Rayner, the manufacturer of the world’s first IOL,

Rayner announced today it’s schedule of events and opportunities for surgeons during the upcoming ESCRS Congress, on the Rayner booth #P207 (Pavilion 2), which includes the launch of the RayOne Trifocal IOL and a preview of the RayOne Hyd...

For those of you who have visited the Rayner website over the last few days, you will have noticed we’re now offering a very different online experience; one that we believe is clearer and more user-friendly.

It’s al...